Does Anti-HBV Therapy Benefit the Prognosis of HBV-Related Hepatocellular Carcinoma Following Hepatectomy?

被引：0
|
作者：
Liang-He Yu
Nan Li
Jie Shi
Wei-Xing Guo
Meng-Chao Wu
Shu-Qun Cheng
机构：
[1] The Second Military Medical University,Eastern Hepatobiliary Surgery Hospital
来源：
Annals of Surgical Oncology | 2014年 / 21卷
关键词：
Remnant Liver Function; Viral Load Group;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Hepatitis B virus (HBV) is an important etiological factor for hepatocarcinogenesis, because HBV DNA load and HBV reactivation are major risks that influence the long-term survival of hepatocellular carcinoma (HCC) patients who underwent hepatectomy and, thus, may cause postoperative liver function deterioration, tumor recurrence, and reduce patient’s overall survival. However, anti-HBV therapy can suppress HBV replication, improve the remnant liver function, render patients better able to tolerate HCC treatments, and may even improve their prognosis. In this paper, an anti-HBV therapy that benefits the prognosis of HBV-related HCC following hepatectomy is reviewed.
引用
收藏
页码：1010 / 1015
页数：5
相关论文
共 50 条
  • [1] Does Anti-HBV Therapy Benefit the Prognosis of HBV-Related Hepatocellular Carcinoma Following Hepatectomy?
    Yu, Liang-He
    Li, Nan
    Shi, Jie
    Guo, Wei-Xing
    Wu, Meng-Chao
    Cheng, Shu-Qun
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (03) : 1010 - 1015
  • [2] Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
    Lu, Huihui
    Yi, Wei
    Sun, Fangfang
    Zeng, Zhan
    Zhang, Lu
    Li, Minghui
    Xie, Yao
    [J]. BIOSAFETY AND HEALTH, 2021, 3 (04) : 190 - 196
  • [3] Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
    Huihui Lu
    Wei Yi
    Fangfang Sun
    Zhan Zeng
    Lu Zhang
    Minghui Li
    Yao Xie
    [J]. 生物安全与健康(英文), 2021, 03 (04) : 190 - 196
  • [4] Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma
    He, Ziming
    Tang, Di
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
    Yu, Liang-He
    Li, Nan
    Cheng, Shu-Qun
    [J]. INTERNATIONAL JOURNAL OF HEPATOLOGY, 2011, 2011
  • [6] Prophylactic Antiviral Therapy Before Hepatectomy Is Beneficial to HBV-Related Hepatocellular Carcinoma Patients with Negative HBV-DNA
    Jiangfa Li
    Zhigao Hu
    Jiming Wang
    Liping Lei
    Jianhua Gong
    Songqing He
    [J]. Indian Journal of Surgery, 2021, 83 : 461 - 466
  • [7] Prophylactic Antiviral Therapy Before Hepatectomy Is Beneficial to HBV-Related Hepatocellular Carcinoma Patients with Negative HBV-DNA
    Li, Jiangfa
    Hu, Zhigao
    Wang, Jiming
    Lei, Liping
    Gong, Jianhua
    He, Songqing
    [J]. INDIAN JOURNAL OF SURGERY, 2021, 83 (02) : 461 - 466
  • [8] Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma
    Li, Chuan
    Li, Zhi-Cheng
    Ma, Liang
    Li, Le-Qun
    Zhong, Jian-Hong
    Xiang, Bang-De
    Gong, Wen-Feng
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (08) : 749 - 756
  • [9] Does chemotherapy prevent HBV-related hepatocellular carcinoma? Pros
    Liaw, Yun-Fan
    [J]. DIGESTIVE AND LIVER DISEASE, 2010, 42 : S293 - S297
  • [10] Does chemotherapy prevent HBV-related hepatocellular carcinoma? Cons
    Colombo, Massimo
    [J]. DIGESTIVE AND LIVER DISEASE, 2010, 42 : S298 - S301
12345